Remove 2014 Remove Drug Pricing Remove Pharmaceutical Manufacturing
article thumbnail

Mallinckrodt pays $260m to settle kickback, rebate fraud charges

pharmaphorum

It says the price increases were imposed “as though a new version of Acthar came on the market in 2013, when in fact, it did not,” which allowed it to ignore all price increases prior to 2013 in its rebate calculations.